WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Chinese astronauts return to earth after six months in space
Beijing slams Washington for spreading false info
Beijing slams Washington for spreading false info
Xi Story: At No Time Should We Focus Only on GDP Growth
Haiti prime minister: transitional council names new leader
European leaders hit back at Macron remark
COP28 sets eyes on AI to fight climate change
Washington moves seen as risking instability
Experts call for halt to toxic water discharge